NCT03747627Completed
BPF Genetics of ILD Study
British Pigeon Fanciers Genetics of Interstitial Lung Disease Study
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
The investigators aim to examine the genetic determinants of interstitial lung disease in a cohort of subjects with regular exposure to pigeons, a known cause of one form of interstitial lung disease known as hypersensitivity pneumonitis. In addition we will examine immunological causes for hypersensitivity pneumonitis in this group. We anticipate our work will provide insights of use to clinicians and patients with hypersensitivity pneumonitis and other interstitial lung diseases.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 475 (actual)
- First submitted
- 14 Nov 2018
- Start date
- 19 Jan 2019
- Primary completion date
- 19 Jan 2025
- Lead sponsor
- University of Dundee
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT03747627
What you commit to
- Study type: Observational
- Participants enrolled: 475
- From 19 Jan 2019 to the primary completion date, 19 Jan 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unwilling to participate
Who the study is looking for
- regular exposure to racing pigeons
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Pigeon Racing Association Meeting Coordinator of this site? Confirm its status | Blackpool | United Kingdom | Unknown status |
| Scottish Homing Union Coordinator of this site? Confirm its status | Lanark | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.